PHC is a marketing term used in the hemp industry for a cannabinoid product that is chemically identical or nearly identical to delta-9 THC, the primary psychoactive compound in marijuana. The name “PHC” doesn’t correspond to a distinct, naturally occurring cannabinoid. Instead, it describes a hemp-derived product that produces the same intoxicating effects as traditional THC, sold under an alternative label to navigate legal gray areas created by the 2018 Farm Bill.
What PHC Actually Is
PHC shares the same molecular formula as delta-9 THC: C21H30O2. Its chemical structure, 6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol, is the same structure listed in the NIH’s PubChem database under delta-9 THC (also known as dronabinol). In practical terms, PHC is THC that has been derived from hemp plants rather than marijuana, then branded with a different name for retail sale.
The hemp industry has produced a wave of alternative cannabinoid names over the past several years, including delta-8 THC, THC-O, HHC, and now PHC. These products typically start with CBD extracted from legal hemp, which is then chemically converted in a lab into THC or a THC-like compound. PHC follows this same pattern. Despite the novel branding, your body processes it the same way it processes THC from any other source.
How Your Body Processes It
Once PHC enters your system, your liver handles it through the same pathway it uses for any form of delta-9 THC. Enzymes in your liver cells first convert THC into an active metabolite called 11-hydroxy-THC, which is actually more potent than THC itself and crosses into the brain more easily. This is why edible forms of THC (and PHC sold as gummies or similar products) often feel stronger than smoked cannabis.
From there, your liver further breaks down 11-hydroxy-THC into an inactive compound called THC-COOH. This inactive metabolite gets tagged with a molecule that makes it water-soluble enough to leave your body through urine, sweat, and feces. The entire process depends on a transport protein in liver cells called FABP1, which shuttles the fat-soluble cannabinoid molecules to the enzymes that break them down. This is the same metabolic chain regardless of whether the THC came from marijuana, a delta-8 product, or something labeled PHC.
Effects and Duration
Because PHC is functionally THC, the effects mirror what you’d expect from any THC product. The onset, peak, and duration depend entirely on how you consume it.
If you vape or smoke a PHC product, effects typically begin within 1 to 10 minutes, peak around 30 minutes, and last 2 to 4 hours total. PHC gummies and other edible forms take longer, usually 30 minutes to 2 hours before you feel anything, with peak effects hitting 2 to 3 hours after consumption and the full experience lasting 4 to 8 hours. THC-infused drinks fall somewhere in between. Products using nano-emulsion technology (where THC particles are broken down to extremely small sizes for faster absorption) can kick in within 10 to 15 minutes, while standard THC beverages take 15 to 30 minutes.
The psychoactive effects themselves are the same as delta-9 THC: euphoria, relaxation, altered perception of time, increased appetite, and potential anxiety or paranoia at higher doses.
PHC and Drug Tests
PHC will cause you to fail a standard drug test. Because your body converts it into the same metabolites as any other form of THC, a urine immunoassay (the most common type of workplace drug screen) cannot distinguish between PHC use and marijuana use. Even hemp products containing less than 0.3% THC can trigger a positive result depending on the amount consumed, according to a position statement from the American College of Medical Toxicology. A product that is essentially pure THC under a different name will absolutely show up.
THC-COOH, the inactive metabolite that drug tests detect, can remain in your system for days to weeks depending on how frequently you use, your body fat percentage, and your metabolism. A single use may clear within a few days for most people, while regular use can produce positive results for 30 days or more.
Legal Status
The 2018 Farm Bill legalized hemp by defining it as cannabis containing less than 0.3% delta-9 THC by dry weight. The law only referenced delta-9 THC specifically, leaving a gap that the hemp industry has exploited by selling various THC analogs and conversions. PHC products have existed in this gray area, where the marketing suggests legality even though the end product is pharmacologically identical to a controlled substance.
That gap is closing. In November 2025, Congress enacted a full-year agriculture appropriations act that reimposed federal controls over certain hemp products designed to deliver intoxicating effects. This means products like PHC face increasing regulatory scrutiny, and their legal status varies significantly by state. Several states had already banned intoxicating hemp derivatives before the federal change.
Safety Concerns
PHC products carry the same risks as THC, plus additional concerns specific to the unregulated hemp-derived cannabinoid market. On the THC side, known risks include liver effects, interactions with other medications (particularly sedatives, anti-anxiety drugs, and sleep aids), gastrointestinal issues like diarrhea and appetite changes, drowsiness, and mood changes including irritability. Animal studies have also raised concerns about male reproductive harm, though this hasn’t been confirmed in humans.
The bigger concern with PHC specifically is the lack of manufacturing oversight. These products are created through chemical conversion processes in labs that may not follow pharmaceutical-grade standards. The FDA has flagged that hemp-derived cannabinoid products can contain unsafe levels of contaminants, including pesticides, heavy metals, and residual solvents from the conversion process. Unlike regulated cannabis products sold in licensed dispensaries, PHC products sold online or in smoke shops rarely undergo independent third-party testing that verifies both potency and purity.
There is no clinical safety data on PHC as a distinct product. No human trials have evaluated its safety profile, appropriate dosing, or long-term effects. What research does exist applies to delta-9 THC broadly, and even that body of evidence has significant gaps. The FDA has not approved any hemp-derived THC product for consumer use outside of one prescription medication.